TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Alphramedic AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
502
|
379
|
362 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
91
|
48
|
56 |
| EBITDA |
89
|
48
|
56 |
| Total assets |
296
|
267
|
227 |
| Current assets |
296
|
267
|
227 |
| Current liabilities |
31
|
31
|
29 |
| Equity capital |
265
|
236
|
198 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.5%
|
88.4%
|
87.2% |
| Turnover per employee |
251
|
190
|
181 |
| Profit as a percentage of turnover |
18.1%
|
12.7%
|
15.5% |
| Return on assets (ROA) |
30.7%
|
18.0%
|
24.7% |
| Current ratio |
954.8%
|
861.3%
|
782.8% |
| Return on equity (ROE) |
34.3%
|
20.3%
|
28.3% |
| Change turnover |
136
|
16
|
69 |
| Change turnover % |
37%
|
4%
|
23% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.